CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
43.51
-0.20 (-0.46%)
Oct 29, 2025, 1:16 PM EDT - Market open
CG Oncology Revenue
CG Oncology had revenue of $551.00K in the twelve months ending June 30, 2025, up 2.23% year-over-year. In the year 2024, CG Oncology had annual revenue of $1.14M with 458.33% growth.
Revenue (ttm)
$551.00K
Revenue Growth
+2.23%
P/S Ratio
6,048.61
Revenue / Employee
$4,876
Employees
113
Market Cap
3.32B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.14M | 935.00K | 458.33% |
| Dec 31, 2023 | 204.00K | 13.00K | 6.81% |
| Dec 31, 2022 | 191.00K | -10.17M | -98.16% |
| Dec 31, 2021 | 10.36M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCGON News
- 19 days ago - CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? - Seeking Alpha
- 7 weeks ago - CG Oncology, Inc. (CGON) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha
- 7 weeks ago - CG Oncology Stock Signals Bullish Momentum Ahead - Benzinga
- 7 weeks ago - CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months - GlobeNewsWire
- 2 months ago - CG Oncology Completes Enrollment in PIVOT-006 - GlobeNewsWire
- 2 months ago - CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 4 months ago - CG Oncology: Looking Undervalued Heading Toward FDA Submission (Upgrade) - Seeking Alpha
- 5 months ago - CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire